Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial

Raja Atreya, Laurent Peyrin-Biroulet, Andrii Klymenko, Monica Augustyn, Igor Bakulin, Dusan Slankamenac, Pal Miheller, Antonio Gasbarrini, Xavier Hébuterne, Karin Arnesson, Thomas Knittel, Jan Kowalski, Markus F Neurath, William J Sandborn, Walter Reinisch

Risultato della ricerca: Contributo in rivista › Articolo in rivista

Fingerprint

Entra nei temi di ricerca di 'Cobitolimod for moderate-to-severe, left-sided ulcerative colitis (CONDUCT): a phase 2b randomised, double-blind, placebo-controlled, dose-ranging induction trial'. Insieme formano una fingerprint unica.

Pharmacology, Toxicology and Pharmaceutical Science